RESUMO
Hereditary spastic paraplegia (HSP) is a neurodegenerative disorder selectively affecting axons of spinal cord motoneurons. Classical mutations in the most frequent HSP gene SPAST (spastin protein) act through haploinsufficiency by abolishing the activity of a C-terminal ATPase domain or by interfering with expression from the affected allele. N-terminal missense variants have been suggested to represent rare polymorphisms, to cause unusually mild phenotypes, and to aggravate the effect of a classical mutation. We confirm these associations for p.S44L but do not detect two other variants (p.E43Q; p.P45Q) in HSP patients and controls. We show that neither of several disease mechanisms associated with classical SPAST mutations applies to the N-terminal variants. Instead, all three alterations enhance the stability of one of two alternative spastin isoforms. Their phenotypic effect may thus not be mediated by haploinsufficiency but by increasing isoform competition for interacting proteins, substrates or oligomerization partners.
Assuntos
Adenosina Trifosfatases/genética , Predisposição Genética para Doença/genética , Mutação de Sentido Incorreto/genética , Paraplegia Espástica Hereditária/genética , Paraplegia Espástica Hereditária/metabolismo , Adolescente , Adulto , Idade de Início , Processamento Alternativo , Criança , Pré-Escolar , Análise Mutacional de DNA , Feminino , Frequência do Gene , Testes Genéticos , Variação Genética , Genótipo , Haplótipos , Humanos , Masculino , Linhagem , Fenótipo , Polimorfismo Genético , Isoformas de Proteínas/genética , Estrutura Terciária de Proteína/genética , Paraplegia Espástica Hereditária/fisiopatologia , EspastinaRESUMO
Angiogenesis is a prerequisite for solid tumor growth and metastasis. Elucidation of the signaling pathways that control tumor angiogenesis constitutes the basis for a rational antiangiogenic tumor therapy. Here we show that the production of vascular endothelial growth factor (VEGF) in HeLa and HL-60 cells is directed by the constitutive photomorphogenesis 9 signalosome (CSN). The CSN is a kinase complex that cooperates with the ubiquitin/26S proteasome system in regulating the stability of proteins involved in signal transduction. VEGF expression is controlled by the transcription factors activator protein (AP)-1, AP-2, SP-1, and hypoxia-inducible factor 1. Inhibition of CSN kinase activity by 50 microM curcumin for 2 h decreases the cellular c-Jun concentration, resulting in a reduction of the VEGF production by approximately 75%. The removal of the inhibitor from the cells led to a time-dependent recovery of endogenous c-Jun that is paralleled by increasing VEGF production. Elevated cellular CSN activity induced by CSN subunit 2 overexpression causes increased VEGF production in HeLa cells. A competitor of CSN-dependent c-Jun phosphorylation, the NH(2)-terminal c-Jun fragment Deltac-Jun(1-226), inhibits VEGF production in HeLa cells. The transcription factors AP-2 and SP-1 act independently of the CSN. They contribute less than a quarter to basal VEGF production. Under our experimental conditions, hypoxia-inducible factor 1alpha protein was not detected. Overexpression of the tumor suppressor p53 reduces VEGF production in HeLa cells. p53 competes with c-Jun for CSN-specific phosphorylation with the consequence of c-Jun destabilization. We conclude that CSN-directed c-Jun signaling mediates high VEGF production in HeLa and HL-60 cells. The data provide an explanation for the known antiangiogenic and antitumorigenic activities of curcumin. Because the CSN regulates the major part of VEGF production in the tested tumor cells, it constitutes a potentially important target for tumor therapy.
Assuntos
Fatores de Crescimento Endotelial/biossíntese , Linfocinas/biossíntese , Proteínas/fisiologia , Complexo do Signalossomo COP9 , Proteínas de Ligação a DNA/metabolismo , Células HL-60/enzimologia , Células HL-60/metabolismo , Células HeLa , Humanos , Proteínas Quinases JNK Ativadas por Mitógeno , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Proteínas Quinases Ativadas por Mitógeno/fisiologia , Complexos Multiproteicos , Peptídeo Hidrolases , Transdução de Sinais/fisiologia , Fator de Transcrição Sp1/metabolismo , Fator de Transcrição AP-1/metabolismo , Fator de Transcrição AP-2 , Fatores de Transcrição/metabolismo , Proteína Supressora de Tumor p53/farmacologia , Proteína Supressora de Tumor p53/fisiologia , Fator A de Crescimento do Endotélio Vascular , Fatores de Crescimento do Endotélio VascularRESUMO
In higher eukaryotic cells, the p53 protein is degraded by the ubiquitin-26S proteasome system mediated by Mdm2 or the human papilloma virus E6 protein. Here we show that COP9 signalosome (CSN)-specific phosphorylation targets human p53 to ubiquitin-26S proteasome-dependent degradation. As visualized by electron microscopy, p53 binds with high affinity to the native CSN complex. p53 interacts via its N-terminus with CSN subunit 5/Jab1 as shown by far-western and pull-down assays. The CSN-specific phosphorylation sites were mapped to the core domain of p53 including Thr155. A phosphorylated peptide, Deltap53(145-164), specifically inhibits CSN-mediated phosphorylation and p53 degradation. Curcumin, a CSN kinase inhibitor, blocks E6-dependent p53 degradation in reticulocyte lysates. Mutation of Thr155 to valine is sufficient to stabilize p53 against E6-dependent degradation in reticulocyte lysates and to reduce binding to Mdm2. The p53T155V mutant accumulates in both HeLa and HL 60 cells and exhibits a mutant (PAb 240+) conformation. It induces the cyclin-dependent inhibitor p21. In HeLa and MCF-7 cells, inhibition of CSN kinase by curcumin or Deltap53(145-164) results in accumulation of endogenous p53.
Assuntos
Peptídeo Hidrolases/metabolismo , Complexo de Endopeptidases do Proteassoma , Proteínas/metabolismo , Transdução de Sinais , Proteína Supressora de Tumor p53/metabolismo , Ubiquitinas/metabolismo , Sequência de Aminoácidos , Sítios de Ligação , Complexo do Signalossomo COP9 , DNA/metabolismo , Proteínas de Ligação a DNA/metabolismo , Células HL-60 , Células HeLa , Humanos , Peptídeos e Proteínas de Sinalização Intracelular , Dados de Sequência Molecular , Complexos Multiproteicos , Mutagênese Sítio-Dirigida , Fosforilação , Proteínas Proto-Oncogênicas p21(ras)/metabolismo , Treonina/genética , Fatores de Transcrição/metabolismo , Proteína Supressora de Tumor p53/genética , Valina/genéticaRESUMO
The 26S proteasome is the major non-lysosomal protease in eukaryotic cells. This multimeric enzyme is the integral component of the ubiquitin-mediated substrate degradation pathway. It consists of two subcomplexes, the 20S proteasome, which forms the proteolytic core, and the 19S regulator (or PA700), which confers ATP dependency and ubiquitinated substrate specificity on the enzyme. Recent biochemical and genetic studies have revealed many of the interactions between the 17 regulatory subunits, yielding an approximation of the 19S complex topology. Inspection of interactions of regulatory subunits with non-subunit proteins reveals patterns that suggest these interactions play a role in 26S proteasome regulation and localization.
Assuntos
Adenosina Trifosfatases/metabolismo , Proteínas de Transporte/metabolismo , Peptídeo Hidrolases/metabolismo , Complexo de Endopeptidases do Proteassoma , Humanos , Proteínas/metabolismo , Proteínas de Ligação a RNA , Especificidade da EspécieRESUMO
The basic region-leucine zipper transcription factor c-Jun regulates gene expression and cell function. It participates in the formation of homo- or heterodimeric complexes that specifically bind to DNA sequences called activating protein 1 (AP-1) sites. The stability and activity of c-Jun is regulated by phosphorylation within the N-terminal activation domain. Mitogen- and stress-activated c-Jun N-terminal kinases (JNKs) were previously the only described enzymes phosphorylating c-Jun at the N terminus in vivo. In this report we demonstrate a JNK-independent activation of c-Jun in vivo directed by the constitutive photomorphogenesis (COP9) signalosome. The overexpression of signalosome subunit 2 (Sgn2), a subunit of the COP9 signalosome, leads to de novo assembly of the complex with a partial incorporation of the overexpressed subunit. The de novo formation of COP9 signalosome parallels an increase of c-Jun protein resulting in elevated AP-1 transcriptional activity. The c-Jun activation caused by Sgn2 overexpression is independent of JNK and mitogen-activated protein kinase kinase 4. The data demonstrate the existence of a novel COP9 signalosome-directed c-Jun activation pathway.
Assuntos
Proteínas de Ligação a DNA/metabolismo , Proteínas de Ligação ao GTP , MAP Quinase Quinase 4 , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Proteínas/metabolismo , Proteínas Proto-Oncogênicas c-jun/metabolismo , Proteínas Repressoras , Fatores de Transcrição/metabolismo , Ativação Transcricional , Complexo do Signalossomo COP9 , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/isolamento & purificação , Eritrócitos/metabolismo , Genes Reporter , Células HeLa , Humanos , Peptídeos e Proteínas de Sinalização Intracelular , Proteínas Quinases JNK Ativadas por Mitógeno , Quinases de Proteína Quinase Ativadas por Mitógeno/metabolismo , Dados de Sequência Molecular , Peptídeo Hidrolases , Fosforilação , Proteínas Tirosina Quinases/metabolismo , Proteínas/genética , Proteínas/isolamento & purificação , Proteínas Recombinantes de Fusão/metabolismo , Proteínas Recombinantes/metabolismo , Deleção de Sequência , Fator de Transcrição AP-1/metabolismo , Fatores de Transcrição/genética , Fatores de Transcrição/isolamento & purificação , TransfecçãoRESUMO
The human core COP9 signalosome consists of eight subunits which have been identified, cloned and sequenced. The components of COP9 signalosome possess homologies with eight non-ATPase regulatory subunits of the 26S proteasome. These polypeptides of the 19S regulator form a reversibly binding subcomplex called the 'lid'. We isolated the 'lid' from human red blood cells and compared it with the COP9 signalosome complex. In addition to the non-ATPase regulatory polypeptides, we found a high molecular mass ATPase copurifying with the human 'lid'. The COP9 signalosome-associated kinase activity is either not at all or only weakly affected by common kinase inhibitors such as 1-(5-Isoquinolinesulfonyl)-2-methyl-piperazine (H7), 5,6-dichloro-1-beta-D-ribofuranosyl-benzimidazole (DRB) or Wortmannin. Curcumin, a tumor suppressor and effector of AP-1 activation, is a potent inhibitor of the COP9 signalosome kinase activity with a Ki of about 10 microM. Since curcumin is known as an inhibitor of the c-Jun N-terminal kinase (JNK) signaling pathway acting upstream of the MAP kinase kinase kinase level, one site of action of the COP9 signalosome might be proximal to regulators on that level.
Assuntos
Proteínas Quinases Ativadas por Mitógeno , Peptídeo Hidrolases/química , Peptídeo Hidrolases/metabolismo , Complexo de Endopeptidases do Proteassoma , Proteínas Quinases/química , Proteínas Quinases/metabolismo , Transdução de Sinais , Animais , Proteínas Quinases Dependentes de Cálcio-Calmodulina/química , Proteínas Quinases Dependentes de Cálcio-Calmodulina/metabolismo , Humanos , Proteínas Quinases JNK Ativadas por Mitógeno , CamundongosRESUMO
An ATP-dependent protease in the intermembrane space of rat liver mitochondria, MISP I (mitochondrial intermembrane space protease), was partially purified and characterised. The protease complex has a molecular mass of 200 kDa and appears to be an oligomeric enzyme complex. The proteolytic activity of the enzyme can be stimulated up to 3-fold by Mg2+ATP. The Km for ATP is 200 microM. Nucleoside triphosphates, but not ADP, AMP, or nonhydrolysable ATP analogues, can substitute for ATP. The protease exhibits multicatalytic properties with chymotrypsin-like, peptidyl-glutamyl-hydrolysing, and trypsin-like activities. Of the latter the trypsin-like activity is not enhanced by ATP. In addition to the hydrolysis of fluorogenic peptide substrates the protease is able to degrade radiolabeled model proteins. The ATP-dependent mitochondrial protease was characterised as a cysteine protease sensitive to hemine. The cross reactivity of an anti-human-S4 antibody raised against an ATPase subunit of the PA700 complex with a component of MISP I indicated a structural relationship. Furthermore, ATP-agarose-binding assays revealed the connection of the peptide hydrolysing activity with an ATP binding domain. The data presented here and a comparison with known ATP-dependent mitochondrial proteases demonstrated that MISP I represents a novel ATP-dependent protease in the mitochondrial intermembrane space of rat liver.
Assuntos
Proteases Dependentes de ATP , Trifosfato de Adenosina/metabolismo , Endopeptidases/isolamento & purificação , Endopeptidases/metabolismo , Mitocôndrias Hepáticas/enzimologia , Serina Endopeptidases/isolamento & purificação , Serina Endopeptidases/metabolismo , Animais , Endopeptidases/efeitos dos fármacos , Masculino , Mitocôndrias Hepáticas/química , Nucleotídeos/metabolismo , Inibidores de Proteases/farmacologia , Ratos , Ratos WistarRESUMO
A novel protein complex has been identified in human cells that has a molecular mass of approximately 450 kDa. It consists of at least eight different subunits including JAB1, the Jun activation-domain binding protein 1, and Trip15, the thyroid hormone receptor-interacting protein 15. The purified complex contains COP9 and COP11 protein homologs and is very similar, if not identical, to the plant COP9 complex involved in light-mediated signal transduction. The isolated JAB1-containing particle has kinase activity that phosphorylates IkappaBalpha, the carboxy terminus of p105, and Ser63 and/or Ser73 of the amino-terminal activation domain of c-Jun. The phosphorylation of c-Jun requires the carboxy terminus of the protein containing the DNA binding and dimerization domains. Three subunits of the new complex--Sgn3, Sgn5/JAB1, and Sgn6--exhibit sequence similarities to regulatory components of the 26S proteasome, which could indicate the existence of common substrate binding sites. Immunofluorescence staining reveals that the new complex shows a subcellular distribution similar to that of the 26S proteasome. The functional relationship of the two particles in regulating transcriptional activity is discussed. Considering the putative role of the complex in signal transduction and its widespread occurrence, we suggest the name JAB1-containing signalosome.
Assuntos
Cisteína Endopeptidases/metabolismo , Complexos Multienzimáticos/metabolismo , Proteínas Quinases/metabolismo , Proteínas/metabolismo , Transdução de Sinais , Sequência de Aminoácidos , Sítios de Ligação , Complexo do Signalossomo COP9 , Clonagem Molecular , Cisteína Endopeptidases/química , DNA Complementar , Proteínas de Ligação a DNA/metabolismo , Humanos , Peptídeos e Proteínas de Sinalização Intracelular , Substâncias Macromoleculares , Dados de Sequência Molecular , Complexos Multienzimáticos/química , Proteínas Nucleares , Peptídeo Hidrolases , Fosforilação , Complexo de Endopeptidases do Proteassoma , Proteínas Quinases/química , Proteínas Quinases/genética , Proteínas/química , Proteínas Proto-Oncogênicas c-jun/metabolismo , Homologia de Sequência de Aminoácidos , Frações Subcelulares/enzimologia , Frações Subcelulares/metabolismo , Fatores de Transcrição/metabolismoRESUMO
We have investigated the usefulness of the fission yeast Schizosaccharomyces pombe as a model organism for the discovery of novel modes of drug resistance in human cells. In fission yeast, overexpression of the essential pad1(+) gene confers pleiotropic drug resistance through a pathway involving an AP-1 transcription factor encoded by pap1(+). We have identified POH1, a human pad1 homologue that can substitute fully for pad1(+) and induce AP-1-dependent drug resistance in fission yeast. POH1 also confers P-glycoprotein-independent resistance to taxol (paclitaxel), doxorubicin, 7-hydroxystaurosporine, and ultraviolet light when transiently overexpressed in mammalian cells. Poh1 is a previously unidentified component of the human 26 S proteasome, a multiprotein complex that degrades proteins targeted for destruction by the ubiquitin pathway. Hence, Poh1 is part of a conserved mechanism that determines cellular susceptibility to cytotoxic agents, perhaps by influencing the ubiquitin-dependent proteolysis of transcription factors.
Assuntos
Cisteína Endopeptidases/fisiologia , Resistência a Múltiplos Medicamentos , Complexos Multienzimáticos/fisiologia , Proteínas de Schizosaccharomyces pombe , Schizosaccharomyces/genética , Transativadores/fisiologia , Fator de Transcrição AP-1/fisiologia , Sequência de Aminoácidos , Animais , Células COS , Clonagem Molecular , Cisteína Endopeptidases/química , Doxorrubicina/metabolismo , Genes Fúngicos , Humanos , Dados de Sequência Molecular , Complexos Multienzimáticos/química , Proteínas Associadas a Pancreatite , Complexo de Endopeptidases do Proteassoma , Alinhamento de Sequência , Homologia de Sequência de AminoácidosRESUMO
We have isolated a fission yeast gene, mts4(+), by complementation of a temperature-sensitive mutation and show that it encodes subunit 2 (S2) of the 19 S regulatory complex of the 26 S protease. mts4(+) is an essential gene, and we show that loss of this subunit causes cells to arrest in metaphase, illustrating the importance of S2 for mitosis. The Mts4 protein is 48% identical to S2 of the human 26 S protease, and the lethal phenotype of the null mts4 allele can be rescued by the human cDNA encoding S2. We provide genetic and physical evidence to suggest that the Mts4 protein interacts with the product of the mts2(+) gene, an ATPase which has previously been shown to be subunit 4 of the 26 S protease.
Assuntos
Adenosina Trifosfatases/metabolismo , Proteínas de Transporte/metabolismo , Proteínas de Ciclo Celular , Inibidor p16 de Quinase Dependente de Ciclina , Cisteína Endopeptidases , Endopeptidases/metabolismo , Mitose , Peptídeo Hidrolases/metabolismo , Complexo de Endopeptidases do Proteassoma , Proteínas de Saccharomyces cerevisiae , Proteínas de Schizosaccharomyces pombe , Peptídeos e Proteínas Associados a Receptores de Fatores de Necrose Tumoral , Proteínas Supressoras de Tumor , Alelos , Sequência de Aminoácidos , Proteínas de Transporte/química , Proteínas de Transporte/genética , Sobrevivência Celular , Inibidor de Quinase Dependente de Ciclina p15 , Endopeptidases/química , Endopeptidases/genética , Proteínas Fúngicas/química , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Humanos , Peptídeos e Proteínas de Sinalização Intracelular , Dados de Sequência Molecular , Peptídeo Hidrolases/química , Ligação Proteica , Conformação Proteica , Proteínas/química , Proteínas/genética , Proteínas/metabolismo , Mapeamento por Restrição , Schizosaccharomyces , Fator 2 Associado a Receptor de TNFRESUMO
The proteasomal system consists of a proteolytic core, the 20 S proteasome, which associates in an ATP-dependent reaction with the 19 S regulatory complex to form the functional 26 S proteasome. In the absence of ATP, the 20 S proteasome forms a complex with the gamma-interferon-inducible 11 S regulator. Both the 20 S proteasome and the 11 S regulator have been implied in the generation of antigenic peptides. The human immunodeficiency virus (HIV)-1 Tat protein causes a number of different effects during acquired immunodeficiency syndrome (AIDS). Here we show that HIV-1 Tat protein strongly inhibits the peptidase activity of the 20 S proteasome and that it interferes with formation of the 20 S proteasome-11 S regulator complex. In addition, it slightly increases the activity of purified 26 S proteasome. These results may explain the mechanism by which HIV-1-infected cells escape cytotoxic T lymphocyte response and at least in part immunodeficiency in AIDS patients.
Assuntos
Cisteína Endopeptidases/metabolismo , Proteínas de Ligação a DNA/farmacologia , Complexos Multienzimáticos/metabolismo , Proteínas Musculares , Proteínas/metabolismo , ATPases Associadas a Diversas Atividades Celulares , Western Blotting , Proteínas de Ligação a DNA/metabolismo , Ativação Enzimática , Corantes Fluorescentes/metabolismo , HIV-1 , Humanos , Cinética , Modelos Moleculares , Peptídeos/metabolismo , Complexo de Endopeptidases do Proteassoma , Conformação ProteicaRESUMO
We have isolated the 26 S protease from the fission yeast Schizosaccharomyces pombe. The affinity-purified enzyme contains the two regulatory ATPases mts2+, a homolog of human S4, and CIM5, a homolog of human MSS1 = S7. We show that mts3+, a homolog of the budding yeast NIN1 protein and human S14, is a true component of the 19 S regulatory complex from the fission yeast. The 26 S proteases purified from two thermosensitive mutants, mts2-1 and mts3-1, which arrest in cell cycle at the restrictive temperature (37 degrees C), have been compared with the wild-type enzyme after growing cells at permissive (25 degrees C) and non-permissive temperatures. We demonstrate that mutated mts2 protein is integrated into the protease complex prepared from mts2 cells, whereas mutated mts3 is not present in the 19 S regulatory complex from mts3 cells. The two mutant 26 S proteases isolated after growing cells at 37 degrees C remain stable for two hours at 37 degrees C as measured by ATP-dependent cleavage of the fluorogenic peptide sucLLVY-MCA. At the restrictive temperature, the mutant 26 S proteases do not degrade ubiquitin-[125I]lysozyme conjugates in an ATP-dependent manner, indicating that mts2+ and mts3+ are essential for ubiquitin conjugate degradation. This explains the conditional lethality of the mutants and the cell-cycle arrest in metaphase to anaphase transition. In addition, our data demonstrate that the ATPases of the 26 S enzyme are not redundant.
Assuntos
Peptídeo Hidrolases/metabolismo , Schizosaccharomyces/enzimologia , Trifosfato de Adenosina/metabolismo , Anáfase , Apirase/metabolismo , Cisteína Endopeptidases/metabolismo , Ativação Enzimática , Eritrócitos/enzimologia , Humanos , Mitose , Complexos Multienzimáticos/metabolismo , Mutação , Peptídeo Hidrolases/química , Peptídeo Hidrolases/isolamento & purificação , Complexo de Endopeptidases do Proteassoma , Temperatura , Ubiquitinas/metabolismoRESUMO
The formation of primary amines via proteolysis was monitored in isolated rat liver, kidney cortex and heart mitochondria in the presence and in the absence of ATP. The highest proteolytic activity was detected in kidney cortex mitochondria with about 120 nmoles primary amines/hour x mg protein. The formation rates of liver mitochondria amounted to about 100 nmoles primary amines/hour x mg protein and in heart mitochondria about 60 nmoles primary amines/hour x mg protein. In all mitochondria investigated an ATP-dependent proteolysis of 20-40 nmoles primary amines/hour x mg protein was detected. The effects of various protease inhibitors were tested in rat liver mitochondria and thiol-specific reagents showed a 35-70% inhibition. The ATP stimulable portion of proteolysis was blocked by hemin, a known inhibitor of ATP-dependent proteases. The localization of the proteolytic activity was tested by fractionation of the compartments of rat liver mitochondria using the flourogenic peptide suc-Leu-Leu-Val-Tyr-MCA as substrate. About 90% of the ATP-dependent peptide cleavage activity were found in the mitochondrial intermembrane space. The characteristics of the enzyme were compared to those of other known mitochondrial ATP-dependent proteases and it was concluded that it represents a novel proteolytic system of the intermembrane space.
Assuntos
Adenosina Trifosfatases/metabolismo , Proteínas de Choque Térmico/metabolismo , Membranas Intracelulares/enzimologia , Mitocôndrias/enzimologia , Serina Endopeptidases/metabolismo , Partículas Submitocôndricas/enzimologia , Proteases Dependentes de ATP , Sequência de Aminoácidos , Animais , Córtex Renal/enzimologia , Cinética , Mitocôndrias Cardíacas/enzimologia , Mitocôndrias Hepáticas/enzimologia , Mitocôndrias Hepáticas/ultraestrutura , Dados de Sequência Molecular , Ratos , Ratos Wistar , Frações Subcelulares/enzimologia , Especificidade por SubstratoRESUMO
The multicatalytic protease (MCP) can be activated by two distinct multisubunit complexes. One is the regulatory component of the 26 S protease, which contains at least 15 distinct subunits. The other is a hexameric activator composed of 31- and 29-kDa subunits. A cDNA for the smaller subunit has been cloned and sequenced. The cDNA encodes a protein of 249 amino acids. Embedded between sequences typical of globular protein domains is a stretch of 28 "alternating" lysine and glutamic acid residues. Similar regions, which we call KEKE motifs, are also found in two MCP subunits, in subunit 12 of the 26 S protease and in a variety of chaperonins including hsp90, hsp70, and calnexin. Expression of the activator cDNA in Escherichia coli produced a functional protein virtually indistinguishable from MCP activator purified directly from red blood cells. The recombinant protein formed three isoelectric species on two-dimensional polyacrylamide gel electrophoresis, and it reacted with antibodies to red blood cell activator. Recombinant activator also bound the multicatalytic protease and stimulated cleavage at the carboxyl terminus of hydrophobic or charged residues. Synthesis of the activator subunit was induced by gamma interferon treatment of HeLa cells. These last two findings have implications for antigen presentation by class I major histocompatibility receptors.
Assuntos
Cisteína Endopeptidases/metabolismo , Interferon gama/farmacologia , Complexos Multienzimáticos/metabolismo , Proteínas/genética , Sequência de Aminoácidos , Sequência de Bases , Linhagem Celular , Clonagem Molecular , DNA Complementar , Ativação Enzimática , Escherichia coli/genética , Células HeLa , Humanos , Dados de Sequência Molecular , Complexo de Endopeptidases do Proteassoma , Biossíntese de Proteínas , Proteínas Recombinantes/genética , Homologia de Sequência de AminoácidosRESUMO
Subunit 6 (S6), an integral component of the 26S protease from human erythrocytes, has been studied by SDS-PAGE, peptide mapping and sequence analysis. S6 was cleaved with CNBr and three internal peptides were sequenced. A comparison with known proteins in Genbank revealed that all three S6 peptides match the predicted sequence of TBP7, Tat-binding protein 7. Based on peptide matches covering more than 10% of the TBP7 sequence, and the fact that the migration of S6 on SDS-PAGE is consistent with the estimated molecular mass for TBP7, we conclude that subunit 6 of the 26S protease is TBP7.
Assuntos
Adenosina Trifosfatases , Proteínas de Ligação a DNA/química , Peptídeo Hidrolases/química , Complexo de Endopeptidases do Proteassoma , Fatores de Transcrição/química , ATPases Associadas a Diversas Atividades Celulares , Sequência de Aminoácidos , Brometo de Cianogênio , Proteínas de Ligação a DNA/isolamento & purificação , Eletroforese em Gel de Poliacrilamida , Eritrócitos/enzimologia , Humanos , Dados de Sequência Molecular , Peso Molecular , Mapeamento de Peptídeos , Fatores de Transcrição/isolamento & purificaçãoRESUMO
Subunit 7 is an integral component of the human erythrocyte 26 S protease. Peptide sequence analysis reveals that 22 amino acids from the N-terminus of subunit 7 correspond exactly to the N-terminus of MSS1, a modulator of HIV gene expression. Additional internal peptides from subunit 7 obtained by CNBr cleavage also match 100% with the deduced amino acid sequence of MSS1. Based on the fact that directly sequenced peptides from subunit 7 are identical to more than 12% of the hypothetical translation product of MSS1, and the fact that the molecular weight of subunit 7 (49 kDa) corresponds to the predicted molecular weight of MSS1 (48,633 Da), we conclude that subunit 7 is MSS1.
Assuntos
Proteínas de Ligação a DNA/metabolismo , Produtos do Gene tat/metabolismo , HIV/genética , HIV/metabolismo , Peptídeo Hidrolases/metabolismo , Complexo de Endopeptidases do Proteassoma , Ativação Transcricional , ATPases Associadas a Diversas Atividades Celulares , Sequência de Aminoácidos , Cromatografia Líquida de Alta Pressão , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/isolamento & purificação , Eletroforese em Gel de Poliacrilamida , Regulação Viral da Expressão Gênica , Humanos , Substâncias Macromoleculares , Dados de Sequência Molecular , Fragmentos de Peptídeos/isolamento & purificação , Peptídeo Hidrolases/genética , Peptídeo Hidrolases/isolamento & purificação , Homologia de Sequência de Aminoácidos , Produtos do Gene tat do Vírus da Imunodeficiência HumanaAssuntos
Cisteína Endopeptidases , Complexos Multienzimáticos , Peptídeo Hidrolases , Sequência de Aminoácidos , Animais , Evolução Biológica , Cisteína Endopeptidases/química , Cisteína Endopeptidases/metabolismo , Dados de Sequência Molecular , Complexos Multienzimáticos/química , Complexos Multienzimáticos/metabolismo , Peptídeo Hidrolases/química , Peptídeo Hidrolases/metabolismo , Complexo de Endopeptidases do Proteassoma , Conformação Proteica , Homologia de Sequência de AminoácidosRESUMO
We have identified and purified a protein complex from human red blood cells that activates the multicatalytic protease (MCP). The complex, which we call the regulator, sediments at 11 S and is composed of 30-kDa subunits. The regulator does not hydrolyze fluorogenic peptides, but when multicatalytic protease and regulator are combined, MCP cleaves succinyl-Leu-Leu-Val-Tyr-7-amido-4-methylcoumarin and Leu-Leu-Glu-p-nitroanilide as much as 60-fold faster. Hydrolysis of several other fluorogenic peptides is stimulated to a lesser extent, and activated MCP does not degrade ubiquitin-lysozyme conjugates, bovine serum albumin, or lysozyme. Latent and activated forms of MCP display similar sensitivity to protease inhibitors, suggesting that activation does not generate new kinds of catalytic sites. In addition, ATP suppresses peptide hydrolysis by activated and latent MCPs to the same extent. Activation involves binding of regulator to MCP, and activated MCP migrates slower on native acrylamide gels. Dissociation of the MCP regulator complex during prolonged sedimentation on glycerol gradients releases active regulator and MCP molecules capable of being reactivated. Moreover, two-dimensional electrophoresis does not reveal changes in MCP or regulator subunits following activation. Thus, activation appears to result from reversible association of regulator subunits with MCP.
Assuntos
Cisteína Endopeptidases/química , Eritrócitos/enzimologia , Complexos Multienzimáticos/química , Trifosfato de Adenosina/metabolismo , Cisteína Endopeptidases/metabolismo , Ativação Enzimática , Humanos , Ponto Isoelétrico , Peso Molecular , Complexos Multienzimáticos/metabolismo , Inibidores de Proteases/farmacologia , Complexo de Endopeptidases do Proteassoma , Especificidade por Substrato , UltracentrifugaçãoRESUMO
Ubiquitinated proteins are degraded by a 26 S ATP-dependent protease. SDS-polyacrylamide gel electrophoresis analysis of the purified 26 S enzyme reveals more than 20 polypeptides ranging in apparent molecular masses from 20 to 110 kDa. Although many of the subunits smaller than 30 kDa are members of the multicatalytic protease family, the identity and function of the larger polypeptides have remained unknown. We report here the cDNA sequence for subunit 4, a 51-kDa chain of the 26 S protease. Subunit 4 belongs to a recently identified eukaryotic ATPase family, which includes proteins involved in peroxisome formation, secretion, and human immunodeficiency virus gene expression. Subunit 4 also shows weak similarity to ClpA, the ATP-binding subunit of the Escherichia coli protease, Clp.